Cargando…

Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer

Lung cancer (LC) is one of the leading causes of cancer occurrence and mortality worldwide. Treatment of patients with advanced and metastatic LC presents a significant challenge, as malignant cells use different mechanisms to resist chemotherapy. Drug resistance (DR) is a complex process that occur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haider, Mohamed, Elsherbeny, Amr, Pittalà, Valeria, Consoli, Valeria, Alghamdi, Maha Ali, Hussain, Zahid, Khoder, Ghalia, Greish, Khaled
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836587/ https://www.ncbi.nlm.nih.gov/pubmed/35163777 http://dx.doi.org/10.3390/ijms23031853

Ejemplares similares

The Potential Role of Sildenafil in Cancer Management through EPR Augmentation
por: Haider, Mohamed, et al.
Publicado: (2021)

Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer
por: Bahman, Fatemah, et al.
Publicado: (2021)

The Promise of Nanotechnology in Personalized Medicine
por: Alghamdi, Maha Ali, et al.
Publicado: (2022)

In Vivo Evaluation of Anti-Nociceptive Effects of Silver Nanoparticles
por: Morsi, Shereen, et al.
Publicado: (2022)

Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect
por: Nehoff, Hayley, et al.
Publicado: (2014)

Heme Oxygenase Modulation Drives Ferroptosis in TNBC Cells
por: Consoli, Valeria, et al.
Publicado: (2022)

Theory and applications of nonparenteral nanomedicines
por: Kesharwani, Prashant, et al.
Publicado: (2020)

Curcumin I-SMA nanomicelles as promising therapeutic tool to tackle bacterial infections
por: Virzì, Nicola F., et al.
Publicado: (2023)

Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia
por: Ciaffaglione, Valeria, et al.
Publicado: (2022)

Selective Targeting of Breast Cancer by Tafuramycin A Using SMA-Nanoassemblies
por: El-Deeb, Ibrahim M., et al.
Publicado: (2021)

Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity
por: Alimoradi, Houman, et al.
Publicado: (2018)

From Far West to East: Joining the Molecular Architecture of Imidazole-like Ligands in HO-1 Complexes
por: Floresta, Giuseppe, et al.
Publicado: (2021)

Novel Heme Oxygenase-1 (HO-1) Inducers Based on Dimethyl Fumarate Structure
por: Sorrenti, Valeria, et al.
Publicado: (2020)

New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells
por: Ciaffaglione, Valeria, et al.
Publicado: (2020)

Optimization and Evaluation of Poly(lactide-co-glycolide) Nanoparticles for Enhanced Cellular Uptake and Efficacy of Paclitaxel in the Treatment of Head and Neck Cancer
por: Haider, Mohamed, et al.
Publicado: (2020)

Helicobacter pylori-induced DNA Methylation as an Epigenetic Modulator of Gastric Cancer: Recent Outcomes and Future Direction
por: Muhammad, Jibran Sualeh, et al.
Publicado: (2019)

Mobile Phones: Reservoirs of Resistant Bacteria during the COVID-19 Pandemic in Abu Dhabi, United Arab Emirates
por: Kayed, Kawthar, et al.
Publicado: (2023)

Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation
por: Greish, Khaled F., et al.
Publicado: (2018)

Plants’ Natural Products as Alternative Promising Anti-Candida Drugs
por: Soliman, Sameh, et al.
Publicado: (2017)

Nanomedicines for Overcoming Cancer Drug Resistance
por: Hu, Tingting, et al.
Publicado: (2022)

Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer
por: Lu, Tao, et al.
Publicado: (2021)

Curcumin–Copper Complex Nanoparticles for the Management of Triple-Negative Breast Cancer
por: Greish, Khaled, et al.
Publicado: (2018)

Particle Nanoarchitectonics for Nanomedicine and Nanotherapeutic Drugs with Special Emphasis on Nasal Drugs and Aging
por: Aziz, Tariq, et al.
Publicado: (2023)

Nanomedicine strategies to target coronavirus
por: Heinrich, Marcel Alexander, et al.
Publicado: (2020)

Impact of Nanomaterials in Biological Systems and Applications in Nanomedicine Field
por: De Matteis, Valeria, et al.
Publicado: (2022)

New challenges in the use of nanomedicine in cancer therapy
por: Rasool, Mahmood, et al.
Publicado: (2022)

Nanomedicine and therapy of lung diseases
por: Garcia, Fabrício de Melo
Publicado: (2014)

Nanomedicine in Lung Cancer Immunotherapy
por: Doroudian, Mohammad, et al.
Publicado: (2023)

Exploring the impact of Helicobacter pylori on gut microbiome composition
por: Dash, Nihar Ranjan, et al.
Publicado: (2019)

Correction: Exploring the impact of Helicobacter pylori on gut microbiome composition
por: Dash, Nihar Ranjan, et al.
Publicado: (2021)

Nanomedicine Strategies for Targeting Tumor Stroma
por: Su, Mei-Chi, et al.
Publicado: (2023)

Mutual Prodrugs of 5‐Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs
por: Ciaffaglione, Valeria, et al.
Publicado: (2021)

Progress in Clinical Trials of Photodynamic Therapy for Solid Tumors and the Role of Nanomedicine
por: Alsaab, Hashem O., et al.
Publicado: (2020)

Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control
por: Hussain, Afzal, et al.
Publicado: (2019)

Erratum: Touil, H.F.Z. et al. Optimum Inhibition of Amphotericin-B-Resistant Candida albicans Strain in Single- and Mixed-Species Biofilms by Candida and Non-Candida Terpenoids. Biomolecules 2020, 10, 342
por: Touil, Hidaya F.Z., et al.
Publicado: (2020)

DNA Methylation-Mediated Overexpression of CXCL1 in Helicobacter pylori-Induced Gastric Cancer: In Silico- and In Vitro-Based Identification of a Potential Biomarker for Carcinogenesis
por: Muhammad, Jibran Sualeh, et al.
Publicado: (2023)

Nanomedicine as a strategy to fight thrombotic diseases
por: Varna, Mariana, et al.
Publicado: (2015)

Targeting strategies for improving the efficacy of nanomedicine in oncology
por: Villaverde, Gonzalo, et al.
Publicado: (2019)

Roadmap and strategy for overcoming infusion reactions to nanomedicines
por: Szebeni, Janos, et al.
Publicado: (2018)

Nanomedicine Strategies to Target Tumor-Associated Macrophages
por: Binnemars-Postma, Karin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7thao62ft92fpissdqt4hgn2ul